Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABAT | P80404 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.38 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23113665 | 1.00 | ABAT (0.39) | ABATALDH1A1KDM4ETSHRSLC6A1 | |
| SCHEMBL3598433 | 0.98 | CES2 (0.41) | ABATALDH1A1KDM4ETSHRSLC6A1 | |
| SCHEMBL28247066 | 0.98 | CES2 (0.41) | ABATALDH1A1KDM4ETSHRSLC6A1 | |
| Benzene SCHEMBL30877908 | 0.96 | ALDH1A1 (0.40) | ABATALDH1A1KDM4ETSHRSLC6A1 | |
| SCHEMBL4617510 | 0.93 | ABAT (0.41) | ABATALDH1A1KDM4ETSHRSLC6A1 | |
| SCHEMBL28247064 | 0.86 | TSHR (0.41) | ABATALDH1A1TSHRSLC6A1SLC6A11 | |
| SCHEMBL16731942 | 0.84 | TSHR (0.39) | ABATALDH1A1KDM4ETSHRSLC6A1 | |
| SCHEMBL28247755 | 0.84 | TSHR (0.39) | ABATALDH1A1KDM4ETSHRSLC6A1 | |
| SCHEMBL91180 | 0.84 | — | — | |
| SCHEMBL468428 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3793514-B1 | FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2022-04-20 | — | — | EP | claimed |
| US-20230341777-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING TERMINAL-BLOCKED REACTION PRODUCT | NISSAN CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230259028-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING REACTION PRODUCT OF HYDANTOIN COMPOUNDS | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| US-11426339-B2 | Organic compounds | GIVAUDAN SA (CH) | 2022-08-30 | — | — | US | disclosed |
| EP-3793514-B1 | FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2022-04-20 | — | — | EP | disclosed |
| EP-3793514-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2021-03-24 | — | — | EP | disclosed |
| US-20210045985-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11426339-B2 | Organic compounds | OR51E2, OR10J3, ELOC | ABAT 794/4885ALDH1A1 85/4885KDM4E 459/4885 |
| US-20210045985-A1 | ORGANIC COMPOUNDS | OR51E2, OR10J3, ELOC | ABAT 794/4885ALDH1A1 85/4885KDM4E 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.